• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards | Inspections
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameBIODIVYSIO OC/OTW STENT SYSTEM
Classification Namestent, coronary
Generic Nameintravascular coronary stent
ApplicantBIOCOMPATIBLES CARDIOVASCULAR, INC.
PMA NumberP000011
Supplement NumberS004
Date Received08/31/2001
Decision Date03/01/2002
Product Code
MAF[ Registered Establishments with MAF ]
Advisory Committee Cardiovascular
Supplement Typenormal 180 day track
Supplement Reason change design/components/specifications - component
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for the biodivysio oc otw in 11 mm, 15 mm, 18 mm, 22 mm and 28 mm stent lengths and 3. 0 mm, 3. 5 mm and 4. 0 mm diameters. The device, as modified, will be marketed under the trade name biodivysio oc otw and is indicated for: "use in subjects with symptomatic ischemic heart disease due to de novo native coronary artery lesions (length <= 25 mm) with a reference vessel diameter ranging from >= 3. 0 mm to <= 4. 0 mm and intended to improve coronary luminal diameter. Long-term outcome (beyond 6 months) for this implant is unknown at present. ".
-
-